The UK has just published a remarkable roadmap to phase out animal testing faster and scale up alternative methods, with concrete measures to support non‑animal science. New £75 million funding will help to make the path to regulation clearer for researchers.
For exposures to the lung, eye and skin, that’s a clear signal: regulators are looking for human‑relevant in vitro data, NAMs need realistic exposure methods at the air/liquid interface, and robust, reproducible setups will decide what actually gets accepted.
That’s where VITROCELL comes in: our exposure systems are already used worldwide to expose cells to gases and complex aerosols and to support next‑generation NAMs, including the AlveoliX AX12 Organ-on-Chip technology. They’re definitely ready for this roadmap.
UK Department for Science, Innovation & Technology: read more here
Please read also the valuable comment by Thomas Hartung (CAAT): read more here
